Paratek Pharmaceuticals: Q4 Earnings Insights

Paratek Pharmaceuticals PRTK reported its Q4 earnings results on Monday, March 14, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Paratek Pharmaceuticals missed estimated earnings by 56.1%, reporting an EPS of $-0.64 versus an estimate of $-0.41.

Revenue was up $15.78 million from the same period last year.

Last quarter the company beat on EPS by $0.08 which was followed by a 2.74% increase in the share price the next day.

Here's a look at Paratek Pharmaceuticals's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	-0.45	0.31	-0.38	-0.04
EPS Actual	-0.37	0.20	-0.39	-0.49
Revenue Estimate	23.82M	60.99M	28.72M	34.04M
Revenue Actual	24.45M	57.49M	16.43M	16.02M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.